Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Mem. Inst. Oswaldo Cruz ; 104(3): 434-440, May 2009. tab
Article in English | LILACS | ID: lil-517007

ABSTRACT

A study was carried out to evaluate the presence of serological markers for the immunodiagnosis of the vertical transmission of toxoplasmosis. We tested the sensitivity, specificity and predictive values (positive and negative) of different serological methods for the early diagnosis of congenital toxoplasmosis. In a prospective longitudinal study, 50 infants with suspected congenital toxoplasmosis were followed up in the ambulatory care centre of Congenital Infections at University Hospital in Goiânia, Goiás, Brazil, from 1 January 2004-30 September 2005. Microparticle Enzyme Immunoassay (MEIA), Enzyme-Linked Fluorescent Assay (ELFA) and Immune-Fluorescent Antibody Technique (IFAT) were used to detect specific IgM anti-Toxoplasma gondii antibodies and a capture ELISA was used to detect specific IgA antibodies. The results showed that 28/50 infants were infected. During the neonatal period, IgM was detected in 39.3 percent (11/28) of those infected infants and IgA was detected in 21.4 percent (6/28). The sensitivity, specificity and predictive values (positive and negative) of each assay were, respectively: MEIA and ELFA: 60.9 percent, 100 percent, 100 percent, 55.0 percent; IFAT: 59.6 percent, 91.7 percent, 93.3 percent, 53.7 percent; IgA capture ELISA: 57.1 percent, 100 percent, 100 percent, 51.2 percent. The presence of specific IgM and IgA antibodies during the neonatal period was not frequent, although it was correlated with the most severe cases of congenital transmission. The results indicate that the absence of congenital disease markers (IgM and IgA) in newborns, even after confirming the absence with several techniques, does not constitute an exclusion criterion for toxoplasmosis.


Subject(s)
Animals , Female , Humans , Infant, Newborn , Antibodies, Protozoan/blood , Immunoassay/methods , Immunoglobulin A/blood , Immunoglobulin M/blood , Toxoplasmosis, Congenital/diagnosis , Longitudinal Studies , Prospective Studies , Sensitivity and Specificity , Toxoplasmosis, Congenital/immunology
2.
Genet. mol. res. (Online) ; 6(2): 461-469, 2007. tab, graf, ilus
Article in English | LILACS | ID: lil-482023

ABSTRACT

Microdeletions in Yq are associated with defects in spermatogenesis, while those in the AZF region are considered critical for germ cell development. We examined microdeletions in the Y chromosomes of patients attended at the Laboratory of Human Reproduction of the Clinical Hospital of the Federal University of Goiás as part of a screening of patients who plan to undergo assisted reproduction. Analysis was made of the AZF region of the Y chromosome in men who had altered spermograms to detect possible microdeletions in Yq. Twenty-three patients with azoospermia and 40 with severe oligozoospermia were analyzed by PCR for the detection of six sequence-tagged sites: sY84 and sY86 for AZFa, sY127 and sY134 for AZFb, and sY254 and sY255 for AZFc. Microdeletions were detected in 28 patients, including 10 azoospermics and 18 severe oligozoospermics. The patients with azoospermia had 43.4% of their microdeletions in the AZFa region, 8.6% in the AZFb region and 17.4% in the AZFc region. In the severe oligozoospermics, 40% were in the AZFa region, 5% in the AZFb region and 5% in the AZFc region. We conclude that microdeletions can be the cause of idiopathic male infertility, supporting conclusions from previous studies.


Subject(s)
Humans , Male , Chromosomes, Human, Y/ultrastructure , Chromosome Deletion , Gene Deletion , Infertility, Male/genetics , Azoospermia/genetics , Brazil , Germ Cells/metabolism , Spermatogenesis , Fertility , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL